Results 11 to 20 of about 6,691 (217)

Acquired Strabismus in Linear Scleroderma of the Face

open access: yesActa Dermato-Venereologica, 2019
is missing (Short communication)
Giorgia Martini   +4 more
doaj   +6 more sources

Linear scleroderma and primary sclerosing cholangitis: An undescribed association

open access: yesIndian Journal of Dermatology, 2020
Linear scleroderma (LS) is clinically characterized by the presence of sclerotic areas of skin, which develop in a linear pattern. Primary sclerosing cholangitis is a cholestatic disorder that can lead to end-stage liver disease.
Iñigo Navarro Fernández   +5 more
doaj   +2 more sources

Linear scleroderma following Blaschko′s lines

open access: goldIndian Journal of Dermatology, Venereology and Leprology, 2005
Blaschko's lines form a pattern, which many diseases are found to follow, but linear scleroderma following Blaschko's lines is a controversial entity rarely reported in the literature. A 24-year-old man presented with multiple linear, atrophic, hyperpigmented lesions punctuated by areas of depigmentations on the left half of the trunk distributed on ...
Amiya Kumar Mukhopadhyay
openalex   +3 more sources

Linear Scleroderma “En Coup De Sabre”: Initial Presentation as Intractable Partial Seizures in a Child

open access: diamondPediatrics and Neonatology, 2009
Linear scleroderma is a form of localized scleroderma characterized by sclerotic lesions distributed in a linear, band-like pattern. The “en coup de sabre” subtype of linear scleroderma is more often associated with systemic morbidity, including ocular ...
Kuo-Liang Chiang   +3 more
doaj   +2 more sources

Linear scleroderma as a rare cause of enophthalmos: a case report [PDF]

open access: goldJournal of Medical Case Reports, 2007
Introduction Enophthalmos is an important physical sign which can be easily missed. Case presentation A 64-year old female presented with painless and progressive shrinking of her right eye. Visual acuity was 6/6 in both eyes.
Fernando Bertie S   +3 more
doaj   +2 more sources

Linear scleroderma “en coup de sabre” with extensive brain involvement—Clinicopathologic correlations and response to anti-Interleukin-6 therapy [PDF]

open access: yesOrphanet Journal of Rare Diseases, 2019
Linear scleroderma “en coup de sabre” (LSES) variant is a cephalic subtype of localized scleroderma that can be associated with extracutaneous stigmata, such as epilepsy, dementia syndromes, as well as focal central nervous system neurologic deficits ...
Cynthia M. Magro   +4 more
doaj   +2 more sources

Neuroimaging and clinical findings in a case of linear scleroderma en coup de sabre [PDF]

open access: yesRadiology Case Reports, 2018
Linear scleroderma “en coup de sabre” is a subset of localized scleroderma with band-like sclerotic lesions typically involving the frontoparietal regions of the scalp.
Ikram E. Duman, MD, Gazanfer Ekinci
doaj   +2 more sources

A Surgical Approach for Stable Lesions of Linear Scleroderma

open access: yesKaohsiung Journal of Medical Sciences, 2010
A 29-year-old Japanese woman presented with alopecia lesions in her occipital region and was diagnosed as linear scleroderma. Topical steroids along with psoralen and UVA light therapy were applied, but the lesion persisted.
Hiroshi Kato   +3 more
doaj   +4 more sources

Histological Changes of Linear Scleroderma “en Coup de Sabre” [PDF]

open access: diamondЛьвівський клінічний вісник, 2014
Introduction. Scleroderma is a chronic disease of unknown aetiology characterized by skin fibrosis and is divided into two clinical entities: localized scleroderma and systemic sclerosis.
Matoshvili M.   +3 more
doaj   +2 more sources

Successful treatment of localized scleroderma using brodalumab: A case report [PDF]

open access: yesSAGE Open Medical Case Reports
We report the first documented use of brodalumab, an IL-17 receptor antagonist, for treating severe linear localized scleroderma refractory to conventional therapies, including methotrexate, mycophenolate mofetil and corticosteroids.
Alexandra Carla Bobica   +4 more
doaj   +2 more sources

Home - About - Disclaimer - Privacy